Cardiovascular Systems Inc (CSII)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1225 OLD HWY 8 NW ST. PAUL, MN 55112

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

Data as of 2021-08-02 08:04:03 -0400
Market Cap1.618 Billion Shares Outstanding40.162 Million Avg 30-day Volume276.497 Thousand
P/E Ratio-69.44162 Dividend Yield EPS-0.616
Price/Sales7.02 Debt to Equity1.28 EBITDA-20.516 Million
Price to Book Value5.98 Forward PE-671.5 Enterprise Value1.428 Billion
Total Cash211.067 Million Current Debt50.447 Million Gross Profit179.891 Million
BETA0.65381 52-week High/Low48.28 / 29.59 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -300.7199
Data provided by IEX Cloud
View SEC Filings from CSII instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 173 183 -5.46% 58 (3.4%) 64 (3.71%) -9.38%
13F shares: 37.566 Million 36.935 Million 1.71% 8.864 Million 8.288 Million 6.95%
% Ownership 93.4671 92.0509 1.54% 22.0537 20.6553 6.77%
New Positions: 13 24 -45.83% 4 10 -60.0%
Increased Positions 57 59 -3.39% 23 17 35.29%
Closed Positions 22 24 -8.33% 9 15 -40.0%
Reduced Positions 78 73 6.85% 27 30 -10.0%
Total Calls 57.491 Thousand 66.7 Thousand -13.81% 7.4 Thousand 35.4 Thousand -79.1%
Total Puts 78.301 Thousand 49.907 Thousand 56.89% 9.4 Thousand 7.4 Thousand 27.03%
PUT/CALL Ratio 1.36 0.75 81.33% 1.27 0.21 504.76%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CSII (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CSII BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

REMPE STEPHEN J. CHIEF HUMAN RESOURCES OFFICER

  • Officer
29,764 2021-05-12 3

WARD SCOTT R. CHAIRMAN AND CEO

  • Officer
  • Director
542,112 2021-05-10 6

ARONSON MARTHA GOLDBERG

  • Director
26,849 2021-05-10 3

ROBB RHONDA J. CHIEF OPERATING OFFICER

  • Officer
146,044 2021-05-10 6

POINTS JEFFREY S. CHIEF FINANCIAL OFFICER

  • Officer
82,177 2021-05-10 7

JAIN SACHIN H.

  • Director
0 2021-01-28 2

SEDO SANDRA CHIEF COMPLIANCE OFFICER

  • Officer
66,822 2020-11-12 7

HASTINGS JOHN M. VP MANUFACTURING & OPERATIONS

  • Officer
36,401 2020-11-12 4

EGELAND RYAN CHIEF MEDICAL OFFICER

  • Officer
55,604 2020-11-12 4

WHITESCARVER DAVID VP OF CORP. DEV. AND IP

  • Officer
45,256 2020-11-12 4

ROSENSTEIN ALEXANDER GENERAL COUNSEL & CORP. SEC.

  • Officer
83,464 2020-08-28 5

WOMACK KELVIN K.

  • Director
0 2020-08-21 2

PAULSEN ERIK

  • Director
200 2020-08-17 2

BROWN EDWARD M

  • Director
107,421 2020-08-07 1

LAWLOR AUGUSTINE

  • Director
27,408 2020-08-07 1

COHN WILLIAM E.

  • Director
4,376 2020-08-07 1

STENBECK STEPHEN

  • Director
3,153 2020-08-07 1

BLACKEY BRENT G

  • Director
94,332 2019-09-03 0

BARTOS SCOTT A.

  • Director
1,699 2018-08-28 0

GILLUND LAURA CHIEF TALENT OFFICER

  • Officer
104,197 2018-08-28 0

BETTERLEY LAURENCE L CHIEF FINANCIAL OFFICER

  • Officer
221,749 2017-08-15 0

KENNY KEVIN J. CHIEF OPERATING OFFICER

  • Officer
151,280 2017-08-15 0

KOEHN PAUL A. SVP MANUFACTURING & OPERATIONS

  • Officer
83,989 2017-05-31 0

TRIGG LESLIE

  • Director
17,282 2016-11-18 0

CAMBER CAPITAL MANAGEMENT LLC

  • 10% Owner
No longer subject to file 2016-09-19 0

MARTIN DAVID PRESIDENT AND CEO

  • Officer
  • Director
481,607 2015-10-08 0

THATCHER ROBERT J. CHIEF HEALTHCARE POLICY OFF'R

  • Officer
126,978 2015-10-02 0

NELSON GLEN D

  • Director
1,399,345 2014-08-11 0

FLAHERTY JAMES E CHIEF ADMINISTRATIVE OFFICER

  • Officer
114,177 2014-05-01 0

FRIEDMAN JOHN H

  • Director
701,687 2013-11-07 0

DISCOVERY GROUP I, LLC

DONOGHUE DANIEL J

MURPHY MICHAEL R

  • 10% Owner
2,027,658 2012-07-17 0

HARTZLER GEOFFREY O

  • Director
116,888 2011-08-08 0

KRAUS SCOTT WILLIAM VP SALES

  • Officer
63,871 2011-07-19 0

DOUGHTY BRIAN VP OF COMMERICAL OPERATIONS

  • Officer
58,914 2011-05-12 0

MAVERICK CAPITAL LTD

MAVERICK CAPITAL MANAGEMENT LLC

AINSLIE LEE S III

  • 10% Owner
No longer subject to file 2010-11-30 0

HOWE ROGER J

  • Director
0 2010-08-13 0

TYSKA PAUL A VP OF BUSINESS DEV

  • Officer
46,821 2010-08-13 0

PETRUCCI GARY M

  • Director
255,036 2009-12-02 0

DUYK GEOFFREY M

  • FORMER DIRECTOR (1)
No longer subject to file 2009-02-25 0

TARRANT ADVISORS, INC

BONDERMAN DAVID

COULTER JAMES G

  • FORMER 10% OWNER (1) (2)FORMER 10% OWNER (1) (2)FORMER 10% OWNER (1) (2)
No longer subject to file 2009-02-25 0

WYSKIEL CHRISTINA W

  • Director
No longer subject to file 2009-02-25 0

WHITEBOX HEDGED HIGH YIELD PARTNERS, L.P.

  • LESS THAN 10% OWNER
0 2008-12-31 0

EASTON HUNT CAPITAL PARTNERS LP

  • 10% Owner
0 2008-12-29 0

BORRELL JOHN R VP OF SALES

  • Officer
  • MBR OF 13(D) GRP OWNG > 10%
23,000 2008-12-29 0

EASTON CAPITAL PARTNERS L P

  • 10% Owner
0 2008-12-29 0

KALLOK MICHAEL J CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
  • MBR OF 13(D) GRP OWNG > 10%
5,500 2008-12-29 0

MITSUI & CO. VENTURE PARTNERS II, L.P.

MITSUI & CO. VENTURE PARTNERS, INC. PRESIDENT AND CEO

MITSUI & CO LTD GENERAL MANAGER

  • Officer
  • 10% Owner
0 2008-12-29 0

MITCHELL DANIEL J

  • Director
1,539,931 2008-12-12 0

MORRISSEY DONALD J JR SR. VP, CORPORATE DEVELOPMENT

  • Officer
70,258 2008-12-04 0

CALHOUN KIRK K

  • Director
0 2008-05-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 22:15:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 21:45:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 21:15:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 20:45:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 20:15:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 19:45:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 19:15:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 18:45:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 18:15:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 17:45:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 17:15:03 UTC -0.3048 0.3648 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 16:45:03 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 16:15:03 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 15:45:03 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 15:15:03 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 14:45:03 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 14:15:03 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 13:45:03 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 13:15:04 UTC -0.3065 0.3865 750000
CARDIOVASCULAR SYSTEMS INC CSII 2021-08-02 12:45:03 UTC -0.3065 0.3865 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Market Neutral Fund CSII -3519.0 shares, $-114965.73 2020-08-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund CSII -41.0 shares, $-1443.61 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CSII -78.0 shares, $-2746.38 2020-03-31 N-PORT
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund CSII -22298.0 shares, $-899055.36 2021-04-30 N-PORT

Elevate your investments